Skip to content
healthcare.dev

ATORVASTATIN CALCIUM

NDC 71610-163, ATORVASTATIN CALCIUM, tablet, film coated, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-163
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205519
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-163 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATORVASTATIN CALCIUM TRIHYDRATE40 mg/1

Pharmacologic classes

HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
71610-163-157161001631515 TABLET, FILM COATED in 1 BOTTLE (71610-163-15)
71610-163-307161001633030 TABLET, FILM COATED in 1 BOTTLE (71610-163-30)
71610-163-457161001634545 TABLET, FILM COATED in 1 BOTTLE (71610-163-45)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ed8e76a5-6b40-47fe-9018-25bfe690a4dd

Use it

Look up 71610-163 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-163 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-163. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.